Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
NCT02663609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2023-06-01
Summary
Chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome.
Conditions
Interventions
- OTHER
-
No intervention
No treatment (intervention) was administered.
Sponsors & Collaborators
-
Corcept Therapeutics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-12-01
- Completion
- 2017-12-01
More Related Trials
-
Cushing's Syndrome Before and After Treatment (CORRECT)
NCT05521529 ·Status: RECRUITING
-
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
NCT00796783 ·Status: TERMINATED
-
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
NCT05804669 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
NCT04308590 ·Status: COMPLETED ·Phase: PHASE3
-
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
NCT05633953 ·Status: COMPLETED
-
Treatment for Endogenous Cushing's Syndrome
NCT01838551 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
NCT00569582 ·Status: COMPLETED ·Phase: PHASE3
-
Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
NCT06607666 ·Status: COMPLETED
-
A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
NCT00088608 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
NCT00889525 ·Status: COMPLETED ·Phase: PHASE3
-
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
NCT05436639 ·Status: COMPLETED ·Phase: PHASE2
-
Updated Diagnostic Cortisol Values for Adrenal Insufficiency
NCT05149638 ·Status: RECRUITING ·Phase: NA
-
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
NCT02468193 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
NCT01915303 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
NCT06930625 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Depression, Peptides, and Steroids in Cushing's Syndrome
NCT00004334 ·Status: UNKNOWN
-
Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)
NCT01546922 ·Status: COMPLETED ·Phase: PHASE4
-
Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
NCT01246739 ·Status: TERMINATED ·Phase: NA
-
Standardized 1µg Adrenocorticotropic Hormone Stimulation Test, and Salivary Cortisol Concentration During the Test
NCT02413944 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
NCT00447499 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults
NCT01088399 ·Status: COMPLETED
-
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
NCT06430528 ·Status: RECRUITING
-
Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004343 ·Status: UNKNOWN
-
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
NCT01371565 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of LCI699 in Cushing's Disease Patients
NCT01331239 ·Status: COMPLETED ·Phase: PHASE2